Cargando…

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study

BACKGROUND: In patients with intracerebral hemorrhage (ICH) and prevalent atrial fibrillation (AF), the optimal stroke prevention strategy is unclear. We sought to estimate the risk of cerebrovascular events among ICH survivors with AF. METHODS: We used the Danish Stroke Registry to identify patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Peter Brønnum, Melgaard, Line, Overvad, Thure Filskov, Jensen, Martin, Larsen, Torben Bjerregaard, Lip, Gregory Y.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311292/ https://www.ncbi.nlm.nih.gov/pubmed/35414198 http://dx.doi.org/10.1161/STROKEAHA.121.038331

Ejemplares similares

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
por: Melgaard, Line, et al.
Publicado: (2021)

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2016)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study
por: Melgaard, Line, et al.
Publicado: (2018)

Positive Predictive Value of Non-Traumatic Bleeding Diagnoses in the Danish National Patient Register
por: Thaarup, Maja, et al.
Publicado: (2023)

Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
por: Højen, Anette Arbjerg, et al.
Publicado: (2021)

Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study
por: Melgaard, Line, et al.
Publicado: (2016)

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
por: Larsen, Torben Bjerregaard, et al.
Publicado: (2016)

Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study
por: Højen, Anette Arbjerg, et al.
Publicado: (2022)

Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs
por: Nielsen, Peter Brønnum, et al.
Publicado: (2021)

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2017)

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study
por: Søgaard, Mette, et al.
Publicado: (2019)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2018)

Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study
por: Steiner, Daniel Kjærgaard, et al.
Publicado: (2022)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
por: Ording, Anne Gulbech, et al.
Publicado: (2022)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
por: Ording, Anne Gulbech, et al.
Publicado: (2021)

Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
por: Ivany, Elena, et al.
Publicado: (2022)

Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
por: Søgaard, Mette, et al.
Publicado: (2019)

Location-Specific Hematoma Volume Cutoff and Clinical Outcomes in Intracerebral Hemorrhage
por: Teo, Kay-Cheong, et al.
Publicado: (2023)

Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation
por: Højen, Anette Arbjerg, et al.
Publicado: (2022)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
por: Larsen, Torben Bjerregaard, et al.
Publicado: (2014)

Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study
por: Højen, Anette Arbjerg, et al.
Publicado: (2019)

Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review
por: Richelsen, Rasmus Kapalu Broge, et al.
Publicado: (2016)

Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study
por: Albertsen, Ida Ehlers, et al.
Publicado: (2022)

Mechanism of Spontaneous Intracerebral Hemorrhage Formation: An Anatomical Specimens-Based Study
por: Rzepliński, Radosław, et al.
Publicado: (2022)

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
por: Wang, Kang-Ling, et al.
Publicado: (2015)

Leakage Sign for Primary Intracerebral Hemorrhage: A Novel Predictor of Hematoma Growth
por: Orito, Kimihiko, et al.
Publicado: (2016)

Relation Between the Corticospinal Tract State and Activities of Daily Living in Patients With Intracerebral Hemorrhage
por: Jang, Sung Ho, et al.
Publicado: (2021)

Cerebrovascular Dysfunction in Atrial Fibrillation
por: Junejo, Rehan T., et al.
Publicado: (2020)

Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study
por: Bodilsen, Jacob, et al.
Publicado: (2021)

Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
por: Lip, Gregory Y H, et al.
Publicado: (2012)

Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial
por: Bath, Philip M., et al.
Publicado: (2019)

Anticoagulation Resumption After Intracerebral Hemorrhage
por: Li, Yan-guang, et al.
Publicado: (2018)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study
por: Lip, Gregory Y.H., et al.
Publicado: (2018)

Validity of Simple Algorithms to Identify Recurrence of Intracerebral Hemorrhage in Two Danish Nationwide Registries
por: Jensen, Mie Micheelsen, et al.
Publicado: (2021)

Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study
por: Søgaard, Mette, et al.
Publicado: (2017)

Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral Hemorrhage
por: Law, Zhe Kang, et al.
Publicado: (2020)

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
por: Rasmussen, Lars Hvilsted, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s07dhme58tjd6fvmfe8jos96pd